Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,720,526
+$120,418 QoQ
Shares Held
10,712
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
#2,077
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. JNJ ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,720,526 | 10,712 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $2,600,108 | 10,637 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,206,500 | 10,662 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,991,781 | 10,742 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,629,689 | 10,669 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,728,384 | 10,422 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,593,712 | 11,020 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $1,783,146 | 11,003 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,482,793 | 10,145 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,558,171 | 9,850 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $1,768,340 | 11,282 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,705,306 | 10,949 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,883,121 | 11,377 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,737,085 | 11,207 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,971,237 | 11,159 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,859,363 | 11,382 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,034,442 | 11,461 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,040,094 | 11,511 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,963,028 | 11,475 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,875,822 | 11,615 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,908,677 | 11,586 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,908,760 | 11,614 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,853,936 | 11,780 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,164,593 | 21,256 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,599,384 | 11,373 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,514,551 | 11,550 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||